NCT00630500View on ClinicalTrials.gov

Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions
Dementia Associated With Parkinson's DiseaseDementia With Lewy Bodies
Interventions
DRUG

Memantine

Tablets, 5 or 10 mg, twice daily

DRUG

Placebo

Tablets corresponding to 5 or 10 mg, twice daily, 6 months

Trial Locations (4)

4005

Stavanger University Hospital, Old Age Psychiatry Clinic, Stavanger

20502

Clinical Memory Research Unit, Neuropsychiatric Clinic, University Hospital Malmo, Malmo

CM16 6TN

Mental Health Unit, Epping

SE1 1UL

King's COllege London, London

All Listed Sponsors
collaborator

King's College London

OTHER

collaborator

Lund University

OTHER

lead

Helse Stavanger HF

OTHER_GOV

NCT00630500 - Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB) | Biotech Hunter | Biotech Hunter